Dr. Daniel Fridberg is an associate professor in the Department of Psychiatry and Behavioral Neuroscience at the University of Chicago. Dr. Fridberg’s program of research focuses on individual differences in alcohol response phenotypes, alcohol biosensors, novel treatment approaches and reactivity to tobacco cues in people who smoke, and neurocognition in substance use disorders. He is especially interested in how basic science research on addiction can inform new treatment approaches for people suffering from those disorders. Dr. Fridberg’s work examining longitudinal predictors of alcohol use disorder (AUD) risk and developing and deploying smartphone-based assessment methods to measure alcohol use and responses in people from across the alcohol-use spectrum has been supported by multiple grants from the National Institutes of Health. In addition to his research program, Dr. Fridberg is a licensed clinical psychologist and provides assessment and treatment services to people with substance use disorders. He is co-director of the University’s Tobacco Cessation Program, which implements the Courage to Quit® smoking cessation program for patients at the University of Chicago Medicine. He also co-directs the Transplant Psychiatry program at the University of Chicago.
Clinical Interests:
Chemical and behavioral addictions
Smoking cessation
Impulse control disorders
Transplant psychology
Mood and anxiety disorders
Cognitive behavioral therapy
Research Interests:
Cognitive and personality mechanisms underlying substance use disorders
Novel treatments for addictive behaviors
Tobacco/alcohol co-use
The University of Chicago
Postdoctoral Fellowship - Addiction Treatment and Research
2014
Indiana University
Postdoctoral Fellowship - Alcohol Research
2013
Indiana University
Ph.D.
2011
VA Connecticut Healthcare System
Predoctoral Internship
2011
IL
- Licensed Clinical Psychologist
Using Mobile Technology to Study Episodes of Alcohol Self-Administration in Daily Life: A Narrative Review.
Using Mobile Technology to Study Episodes of Alcohol Self-Administration in Daily Life: A Narrative Review. Curr Addict Rep. 2026; 13(1):83.
PMID: 42732215
Predictors of treatment engagement in a group-based, telehealth smoking cessation program.
Predictors of treatment engagement in a group-based, telehealth smoking cessation program. Prev Med Rep. 2026 Aug; 68:103544.
PMID: 42375166
Expectations versus reality: Associations among anticipated, natural environment, and laboratory-derived alcohol stimulation, sedation, and reward.
Expectations versus reality: Associations among anticipated, natural environment, and laboratory-derived alcohol stimulation, sedation, and reward. Exp Clin Psychopharmacol. 2026 Aug; 34(4):435-443.
PMID: 41785114
Living Up to Their Name: Blackout Rage Gallons (BORGs) Marked by High-Intensity Drinking and Alcohol Consequences in College Students.
Living Up to Their Name: Blackout Rage Gallons (BORGs) Marked by High-Intensity Drinking and Alcohol Consequences in College Students. J Stud Alcohol Drugs. 2026 Sep; 87(5):930-938.
PMID: 41636174
Characterization of Tobacco Cessation Services, Pharmacotherapies, and Policies at Adolescent-serving Substance Use Treatment Facilities in 2023.
Characterization of Tobacco Cessation Services, Pharmacotherapies, and Policies at Adolescent-serving Substance Use Treatment Facilities in 2023. J Addict Med. 2025 Nov 25.
PMID: 41287149
Reactivity to electronic nicotine delivery system (ENDS) cues in adults who smoke cigarettes and vape cannabis.
Reactivity to electronic nicotine delivery system (ENDS) cues in adults who smoke cigarettes and vape cannabis. Addict Behav. 2026 Jan; 172:108502.
PMID: 40997552
Development of an alcohol biosensor non-wear algorithm: laboratory-based machine learning and field-based deployment.
Development of an alcohol biosensor non-wear algorithm: laboratory-based machine learning and field-based deployment. Sci Rep. 2025 Aug 25; 15(1):31154.
PMID: 40851098
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study.
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study. J Addict Med. 2026 May-Jun 01; 20(3):375-380.
PMID: 40792626
Examining Electronic Nicotine Delivery System (ENDS) Cue Reactivity Using a Remote Platform: Cigarette and ENDS Desire in Dual Users.
Examining Electronic Nicotine Delivery System (ENDS) Cue Reactivity Using a Remote Platform: Cigarette and ENDS Desire in Dual Users. Nicotine Tob Res. 2025 Jul 22; 27(8):1332-1339.
PMID: 39826089
Pace of alcohol drinking during in natural-environment drinking is associated with heightened alcohol-related reward and negative consequences in risky drinkers.
Pace of alcohol drinking during in natural-environment drinking is associated with heightened alcohol-related reward and negative consequences in risky drinkers. Psychopharmacology (Berl). 2025 Aug; 242(8):1769-1781.
PMID: 39961888